Psychiatry and Neurology, Neurology · Los Angeles, CA
NPI
1114940731
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
300 Medical Plaza, #b200
Los Angeles, CA, 90095
Phone (310) 794-1195
Groups this clinician bills Medicare through
Medicare paid, 2024
$58K
506 services
Medicare patients, 2024
195
Average age 75
Drug cost, 2024
$2.7M
2,478 prescriptions
Company payments, 2025
$1,595
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jeff M Bronstein was code 99215 (office e&m - established), 311 times for 144 patients. In total Jeff M Bronstein billed 506 services in 19 codes, and Medicare paid $58K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-01-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 311 | 144 | $135.76 | $42K |
| 99214 Office E&M - Established | Office | 60 | 46 | $102.13 | $6,128 |
| 99233 Hospital E&M - Subsequent | Facility | 34 | 14 | $98.46 | $3,348 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 30 | 20 | $12.88 | $386 |
| 99205 Office E&M - New | Office | 12 | 12 | $170.51 | $2,046 |
By year: 2022 $52K for 405 services; 2023 $59K for 474 services; 2024 $58K for 506 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jeff M Bronstein prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 285 prescriptions and refills. In total Jeff M Bronstein wrote 2,478 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 285 | 569 | 71 | $15K |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 202 | 418 | 52 | $17K |
| Nuplazid Pimavanserin Tartrate | 174 | 238 | 25 | $1.2M |
| Rytary Carbidopa/Levodopa | 148 | 215 | 23 | $167K |
| Donepezil Hcl Generic | 134 | 249 | 31 | $1,791 |
| Carbidopa-Levodopa-Entacapone Carbidopa/Levodopa/Entacapone | 118 | 208 | 25 | $32K |
| Quetiapine Fumarate Generic | 97 | 168 | 24 | $2,256 |
| Rasagiline Mesylate Generic | 91 | 230 | 22 | $21K |
| Escitalopram Oxalate Generic | 85 | 221 | 24 | $1,259 |
| Amantadine Amantadine Hcl | 79 | 162 | 15 | $6,741 |
| Clonazepam Generic | 77 | 113 | 18 | $806 |
| Mirtazapine Generic | 60 | 112 | 19 | $1,220 |
| Trazodone Hcl Generic | 59 | 121 | 17 | $883 |
| Ongentys Opicapone | 54 | 71 | Under 11 | $46K |
| Ropinirole Er Ropinirole Hcl | 43 | 95 | Under 11 | $6,178 |
Brand drugs: - claims; generic drugs: 1,813 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jeff M Bronstein $1,595 ($1,595 in general payments such as food, travel and fees) from 2 companies. The largest payer was Bayer Healthcare Pharmaceuticals Inc. with $1,595.
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 10 | $1,595 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.